# TQL-block for Laparoscopic Hemicolectomy

> **NCT03570541** · PHASE4 · COMPLETED · sponsor: **Zealand University Hospital** · enrollment: 69 (actual)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** Ropivacaine
- **DRUG:** Acetaminophen
- **DEVICE:** Patient controlled analgesia
- **DRUG:** Morphine
- **DRUG:** Saline
- **DIAGNOSTIC_TEST:** Blood samples
- **BEHAVIORAL:** Quality of recovery-15 questionaire
- **DIAGNOSTIC_TEST:** Orthostatic hypotension

## Key facts

- **NCT ID:** NCT03570541
- **Lead sponsor:** Zealand University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-28
- **Primary completion:** 2020-12-05
- **Final completion:** 2021-01-03
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2021-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03570541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03570541, "TQL-block for Laparoscopic Hemicolectomy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03570541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*